Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tenax Therapeutics (TENX)

Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tenax Therapeutics 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 USA

www.tenaxthera.com P: 919-855-2100 F: 919-855-2133

Description:

Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. The Company specializes in creating pharmaceuticals and medical devices in the fields of oxygen therapeutics, blood substitutes, and liquid ventilation and implanted glucose sensing. Tenax Therapeutics Inc., formerly known as Oxygen Biotherapeutics, Inc., is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 6,971
Enterprise Value, $K -2,819
Shares Outstanding, K 1,958
Annual Sales, $ 0 K
Annual Net Income, $ -7,710 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,230 K
EBIT, $ -8,240 K
EBITDA, $ -8,230 K
60-Month Beta 2.25
% of Insider Shareholders 1.85%
% of Institutional Shareholders 1.67%
Float, K 1,922
% Float 98.15%
Short Volume Ratio 0.47

Growth:

1-Year Return -87.01%
3-Year Return -99.88%
5-Year Return -99.85%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -6.40 on 11/13/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -22.40
EPS Growth vs. Prev Qtr -60.00%
EPS Growth vs. Prev Year 96.36%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-80 on 01/03/24

TENX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -65.79%
Return-on-Assets % -58.32%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.13
Book Value/Share 27.00
Interest Coverage -384.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar